Abstract
This chapter will focus on the technological and clinical evolution of conventionally fractionated external-beam radiotherapy against prostate cancer. Advances in imaging and radiotherapy techniques during treatment planning and delivery, such as 3D conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT), and image-guided radiotherapy (IGRT) resulted in a more accurate definition of the prostate target volume and reduced complications due to better sparing of adjacent normal tissues. In consequence, an increased therapeutic dose can now be delivered more safely with a significant superiority of biochemical disease-free survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vicini FA, Kestin LL, Martinez AA (1999) The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 45:553–561
Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116
Morgan PB, Hanlon AL, Horwitz EM et al (2007) Radiation dose and late failures in prostate cancer. Int J Radiat Oncol Biol Phys 67:1074–1081
Perez CA, Michalski JM, Purdy JA et al (2000) Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 47:629–637
Kuban DA, Tucker SL, Dong L et al (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67–74
Cahlon O, Zelefsky MJ, Shippy A et al (2008) Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71:330–337
Zietman AL, Bae K, Slater JD et al (2010) Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95–09. J Clin Oncol 28:1106–1111
Trichter F, Ennis RD (2003) Prostate localization using transabdominal ultrasound imaging. Int J Radiat Oncol Biol Phys 56:1225–1233
Chung PW, Haycocks T, Brown T et al (2004) On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 60:329–334
Hammoud R, Patel SH, Pradhan D et al (2008) Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomography. Int J Radiat Oncol Biol Phys 71:265–273
Pilepich MV, Prasad SC, Perez CA (1982) Computed tomography in definitive radiotherapy of prostatic carcinoma, part 2: definition of target volume. Int J Radiat Oncol Biol Phys 8:235–239
De Meerleer GO, Vakaet LA, De Gersem WR et al (2000) Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 47:639–648
Little DJ, Dong L, Levy LB et al (2003) Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys 56:1218–1224
Beltran C, Herman MG, Davis BJ (2008) Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiat Oncol Biol Phys 70:289–295
Kuban DA, Levy LB, Cheung MR et al (2011) Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys 79:1310–1317
Nguyen PL, Chen RC, Hoffman KE et al (2010) Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys 78:1081–1085
Enke C, Ayyangar K, Saw CB, Zhen W, Thompson RB, Raman NV (2002) Inter-observer variation in prostate localization utilizing BAT. Int J Radiat Oncol 54:269
McNair HA, Mangar SA, Coffey J et al (2006) A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapy. Int J Radiat Oncol Biol Phys 65:678–687
Langen KM, Willoughby TR, Meeks SL et al (2008) Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 71:1084–1090
King CR, Lehmann J, Adler JR et al (2003) CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat 2:25–30
Xie Y, Djajaputra D, King CR et al (2008) Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 72:236–246
Ghilezan MJ, Jaffray DA, Siewerdsen JH et al (2005) Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 62:406–417
Kotte AN, Hofman P, Lagendijk JJ et al (2007) Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 69:419–425
Vapiwala N, Rajendran RR, Plastaras JP, Kassaee A (2008) Real-time prostate motion is highly variable among patients undergoing prostate radiotherapy (RT) with electromagnetic localization and tracking. Int J Radiat Oncol 72:S350–S351
Khan DC, Tropper S, Liu P, Mantz CA (2009) Patient-reported reduction in acute GU and GI side effects for prostate cancer patients treated with 81 Gy IMRT using reduced PTV margins and electromagnetic tracking. Int J Radiat Oncol 75:S113–S114
Wang X, Zhang X, Dong L et al (2004) Development of methods for beam angle optimization for IMRT using an accelerated exhaustive search strategy. Int J Radiat Oncol Biol Phys 60:1325–1337
Adler JR Jr, Chang SD (2009) Cyberknife image-guided radiosurgery. Neurosurgery 64:A1
Choi BO, Choi IB, Jang HS et al (2008) Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 8:351
Collins BT, Vahdat S, Erickson K et al (2009) Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. J Hematol Oncol 2:1
Gagnon GJ, Nasr NM, Liao JJ et al (2009) Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients. Neurosurgery 64:297–306; discussion 306–297
Hara W, Loo BW Jr, Goffinet DR et al (2008) Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 71:393–400
Fuller DB, Naitoh J, Lee C et al (2008) Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 70:1588–1597
King CR, Brooks JD, Gill H et al (2009) Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 73:1043–1048
Koong AC, Le QT, Ho A et al (2004) Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58:1017–1021
Katz AJ, Santoro MI (2009) Cyberknife radiosurgery for early carcinoma of the prostate: a three year experience. Int J Radiat Oncol 75:S312–S313
Heijmen B, van de Water S, Breedveld S et al (2009) A variable circular collimator: a time-efficient alternative for a multi-leaf collimator in robotic radiosurgery? Int J Radiat Oncol 75(3 Suppl):S674–S675
Fuller DB (2009) Comparison of Virtual HDR Prostate Treatment Plans Created with Fixed and Variable Aperture Collimators. Presented to the ASTRO 2009 Annual Meeting, Chicago, IL
Fan J, Li J, Price R, Jin L, Wang L, Chen L, Ma C (2010) MLC-based CyberKnife radiotherapy for prostate cancer. American Society of Radiation Oncology, Philadelphia
Kupelian PA, Willoughby TR, Reddy CA et al (2007) Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 68:1424–1430
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fuller, D.B. (2012). The Evolution of Conventionally Fractionated External-Beam Radiotherapy: Contemporary Techniques (3D-CRT/IMRT/IGRT). In: Ponsky, L., Fuller, D., Meier, R., Ma, C. (eds) Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11495-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-11495-3_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11494-6
Online ISBN: 978-3-642-11495-3
eBook Packages: MedicineMedicine (R0)